Tezepelumab for asthma with current or previous smoking habit: Case series
Tezepelumab effectively treated severe asthma in a current smoker and a former smoker, suggesting that thymic stromal lymphopoietin is involved in the pathogenesis of severe asthma in these patients. Tezepelumab may additionally be used for severe asthma in current and former smokers.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Journal of Allergy and Clinical Immunology: Global |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772829325000219 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1825199287716282368 |
|---|---|
| author | Yoshiro Kai, MD, PhD Kentaro Suzuki, MD Ryosuke Kataoka, MD |
| author_facet | Yoshiro Kai, MD, PhD Kentaro Suzuki, MD Ryosuke Kataoka, MD |
| author_sort | Yoshiro Kai, MD, PhD |
| collection | DOAJ |
| description | Tezepelumab effectively treated severe asthma in a current smoker and a former smoker, suggesting that thymic stromal lymphopoietin is involved in the pathogenesis of severe asthma in these patients. Tezepelumab may additionally be used for severe asthma in current and former smokers. |
| format | Article |
| id | doaj-art-b97979f3a3c64b38a4e7f56c4fa6f7de |
| institution | Kabale University |
| issn | 2772-8293 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Allergy and Clinical Immunology: Global |
| spelling | doaj-art-b97979f3a3c64b38a4e7f56c4fa6f7de2025-02-08T05:01:45ZengElsevierJournal of Allergy and Clinical Immunology: Global2772-82932025-05-0142100420Tezepelumab for asthma with current or previous smoking habit: Case seriesYoshiro Kai, MD, PhD0Kentaro Suzuki, MD1Ryosuke Kataoka, MD2Department of Respiratory Medicine, Minami-Nara General Medical Center, Nara, Japan; Department of Respiratory Medicine, Nara Medical University, Nara, Japan; Corresponding author: Yoshiro Kai, MD, PhD, Department of Respiratory Medicine; Minami-Nara General Medical Center; 8-1 Fukugami, Oyodo-cho, Yoshino-gun, Nara 638-8551, Japan.Department of Respiratory Medicine, Minami-Nara General Medical Center, Nara, JapanDepartment of Respiratory Medicine, Minami-Nara General Medical Center, Nara, JapanTezepelumab effectively treated severe asthma in a current smoker and a former smoker, suggesting that thymic stromal lymphopoietin is involved in the pathogenesis of severe asthma in these patients. Tezepelumab may additionally be used for severe asthma in current and former smokers.http://www.sciencedirect.com/science/article/pii/S2772829325000219AsthmasmokerTSLPtezepelumab |
| spellingShingle | Yoshiro Kai, MD, PhD Kentaro Suzuki, MD Ryosuke Kataoka, MD Tezepelumab for asthma with current or previous smoking habit: Case series Journal of Allergy and Clinical Immunology: Global Asthma smoker TSLP tezepelumab |
| title | Tezepelumab for asthma with current or previous smoking habit: Case series |
| title_full | Tezepelumab for asthma with current or previous smoking habit: Case series |
| title_fullStr | Tezepelumab for asthma with current or previous smoking habit: Case series |
| title_full_unstemmed | Tezepelumab for asthma with current or previous smoking habit: Case series |
| title_short | Tezepelumab for asthma with current or previous smoking habit: Case series |
| title_sort | tezepelumab for asthma with current or previous smoking habit case series |
| topic | Asthma smoker TSLP tezepelumab |
| url | http://www.sciencedirect.com/science/article/pii/S2772829325000219 |
| work_keys_str_mv | AT yoshirokaimdphd tezepelumabforasthmawithcurrentorprevioussmokinghabitcaseseries AT kentarosuzukimd tezepelumabforasthmawithcurrentorprevioussmokinghabitcaseseries AT ryosukekataokamd tezepelumabforasthmawithcurrentorprevioussmokinghabitcaseseries |